Clinical Trial Update: A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib

View source ↗

Summary

A completed clinical trial evaluating serum protein profiling in non-small cell lung cancer patients treated with gefitinib or erlotinib. The study status is re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)
• Tarceva (erlotinib)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Non Small Cell Lung Cancer | Status: COMPLETED